Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial-Reference-Cited by-同舟云学术

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

Published:2013-06-06 Issue:8 Volume:97 Page:989-993
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:Br J Ophthalmol

Author:

Day Douglas G,Walters Thomas R,Schwartz Gail F,Mundorf Thomas K,Liu Charlie,Schiffman Rhett M,Bejanian Marina

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference24 articles.

1. Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: a closer look at the agonist properties of bimatoprost and the prostamides;Smid;Clin Ophthalmol,2009

2. Bimatoprost: a novel antiglaucoma agent;Woodward;Cardiovasc Drug Rev,2004

3. Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension;Curran;Drugs Aging,2009

4. A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure;van der Valk;J Clin Epidemiol,2009

5. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials;Aptel;J Glaucoma,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preservatives and ocular surface disease: A review;The Ocular Surface;2024-10

2. From Eye Care to Hair Growth: Bimatoprost;Pharmaceuticals;2024-04-27

3. Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial;Journal of Glaucoma;2024-03-04

4. A Monocular Trial Study between Different Prostaglandin Eyedrops of Different Formulas on Patient Satisfaction;Journal of the Korean Glaucoma Society;2024

5. How latanoprost changed glaucoma management;Acta Ophthalmologica;2023-06-23